Skip to main content

Table 2 Distribution of the respondents by their clinical presentation and investigation (n = 44)

From: Clinical profile and demographic characteristics of moderate and severe hemophilia patients in a tertiary care hospital of Bangladesh

Clinical presentation

Total (n = 44)

Severity of hemophilia

p value

Severe (n = 19)

Moderate (n = 25)

Mode of bleeding

 Spontaneous

44 (100)

19 (100)

25 (100)

 After minor trauma

44 (100)

19 (100)

25 (100)

 After major trauma

44 (100)

19 (100)

25 (100)

Joint swelling

 Yes

43 (97.7)

18 (94.7)

25 (100)

0.432

 No

1 (2.3)

1 (5.3)

0

Target joint

 Knee

31 (70.5)

11 (57.9)

20 (80.0)

0.268

 Elbow

7 (15.9)

4 (21.1)

3 (12.0)

 Ankle

2 (4.5)

1 (5.3)

1 (4.0)

 Shoulder

2 (4.5)

2 (10.5)

0

 Hip

1 (2.3)

0

1 (4.0)

 None

1 (2.3)

1 (5.3)

0

Soft tissue/muscle swelling

 Yes

32 (72.7)

15 (78.9)

17 (68.0)

0.419

 No

12 (27.3)

4 (21.1)

8 (32.0)

Muscle wasting

 Yes

43 (97.7)

18 (94.7)

25 (100.0)

0.432

 No

1 (2.3)

1 (5.3)

0

Bleeding/ecchymosis from skin/other orifices

 Yes

33 (75.0)

17 (89.5)

16 (64.0)

0.081

 No

11 (25.0)

2 (10.5)

9 (36.0)

Functional status

 Unrestricted activity

1 (2.3)

1 (5.3)

0

0.416

 Full school/work with some limitation

26 (59.1)

10 (52.6)

16 (64.0)

 Restricted school/work

16 (36.4)

7 (36.8)

9 (36.0)

 Restricted self-care

1 (2.3)

1 (5.3)

0

Investigation

APTT (s)

89.30 (49.4–120.0)

88.65 (72.0–98.0)

89.4 (49.4–120.0)

0.951

X-ray of the affected joint

 Joint changes present

40 (93.0)

17 (89.5)

23 (95.8)

0.416

 No change

3 (7.0)

2 (10.5)

1 (4.2)

 Missing value

1

  

Ultrasonogram of suspected muscle group

 Normal

14 (34.1)

5 (29.4)

9 (37.5)

0.591

 Muscle Hematoma

27 (65.9)

12 (70.6)

15 (62.5)

 Missing value

3

  

Ultrasonogram of whole abdomen

 Normal

31 (72.1)

14 (73.7)

17 (70.8)

0.836

 Retroperitoneal hemorrhage

12 (27.9)

5 (26.3)

7 (29.2)

 Missing value

1

   
  1. Data expressed as n(%) and median(min-max) where appropriate
  2. p value was determined by Fisher’s Exact, Chi-square test, and Mann–Whitney U test where appropriate
  3. APTT Activated Partial Thromboplastin Time